Market Overview:
The global pain management drugs and devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and technological advancements in pain management drugs and devices. Based on type, the global pain management drugs and devices market is segmented into pharmaceuticals and devices. The pharmaceuticals segment is further sub-segmented into analgesics, anti-inflammatory agents, neuromodulators, anesthetics & sedatives, and other pharmaceuticals. The analgesics sub-segment dominates the overall pharmaceuticals segment owing to their high usage for treating various types of chronic pain conditions such as cancer pain, neuropathicpain ,and musculoskeletalpain . Among these applications segments, cancerPain holds a dominant share in terms of revenue contribution followed by burnPain .
Product Definition:
Pain management drugs and devices are used to treat pain. They can help reduce pain, make it easier to move around, and improve your quality of life.
Pharmaceuticals:
Pharmaceuticals are the drugs and medicines used to treat diseases. They can be categorized into two types: Over the counter (OTC) and prescription. OTC pharmaceuticals include products such as cough syrups, cold preparations, vitamins, etc., while prescription drugs are those that require a doctor's approval before purchase.
Devices:
The global devices and it's usage in pain management drugs and devices market size was valued at USD 6.1 billion in 2016. It is expected to witness a CAGR of XX% during the forecast period, owing to increasing prevalence of chronic pain disorders such as arthritis, osteoporosis, ankylosing spondylitis, lower back pain among others that require long-term treatment with minimal relief options available commercially.
Application Insights:
The market is segmented by application into burn pain, cancer pain, dental/facial pain, migraine headache pain, musculoskeletal pain, neuropathic pains and obstetrical pains. The cancer segment held the largest share of the global market in 2017 owing to increasing cases of cancer across the globe. According to WHO¢â‚¬â„¢s estimates for 2016-2017; over 1 in 6 people will develop cancer during their lifetime and around 9 out of 10 cases are diagnosed in developing countries.
According to a study published by NCBI in 2018; around 1.7 million new cases were reported globally which resulted in deaths of approximately 662 thousand people annually from 2012 till 2015 due to lung-, breast- and colon-cancer combined (excluding other cancers).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing cases of chronic pain and other associated disorders, rising awareness about treatment options, availability of a well-developed healthcare system, and presence of key companies engaged in promoting sales & distribution as well as manufacturing/development of drugs & devices.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure; growing patient awareness; expansion in retail pharmacies; increase in per capita income levels coupled with rise in consumer purchasing power. Furthermore, government initiatives for controlling diabetes are expected favorably impact regional market growth during the estimated time span.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%, and it is projected to increase to 30% by 2030. This will create a large pool of patients who will require treatment for their chronic pain, thereby driving the demand for pain management drugs and devices.
- Rising geriatric population: The global geriatric population is expected to grow at a CAGR of 3.4% from 2016-2026, which will lead to an increase in the number of elderly patients with various types of pain conditions. This will create a high demand for effective and safe analgesics and devices that can provide relief from chronicpain in this population segment.
- Technological advancements: There has been significant progress in the fieldof analgesic drug discovery over the past few years, with several novel drugs being developed specifically for treating various typesofpain conditions .This trend is likelyto continue in future, resultingin better optionsfor managingpainand improving patient outcomes .In addition, there has been considerable advancement in device technology over the past few years ,with new devices being developed specifically for treating different typesofchronicpainsuch as neuropathicpainand cancer-related pains .This trendis also likelyto continuein future ,resultingin improvedtreatment optionsforpatients sufferingfrom theseconditions .All these factors are expected to drive growth prospectsforthe Pain Management Drugs & Devices marketoverthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pain Management Drugs & Devices Market Research Report
By Type
Pharmaceuticals, Devices
By Application
Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain
By Companies
Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Pain Management Drugs & Devices Market Report Segments:
The global Pain Management Drugs & Devices market is segmented on the basis of:
Types
Pharmaceuticals, Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbvie Inc.
- Astrazeneca Depomed Inc.
- Djo Global Inc.
- Eli Lilly & Co.
- Endo International
- Glaxosmithkline
- Hisamitsu Pharmaceutical Co. Inc.
- Johnson & Johnson
- Medtronic Inc.
- Novartis International Ag
- Pfizer
- Purdue Pharmaceuticals Lp
- Abbott
Highlights of The Pain Management Drugs & Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceuticals
- Devices
- By Application:
- Burn Pain
- Cancer Pain
- Dental/Facial Pain
- Migraine Headache Pain
- Musculoskeletal Pain
- Neuropathic Pain
- Obstetrical Pain
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pain Management Drugs & Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pain management drugs and devices are medications or devices that are used to reduce pain. These medications can be taken by mouth, injected into a muscle, or applied topically. Devices used to reduce pain may include heat pads, ice packs, massage therapy machines, and acupuncture needles.
Some of the major companies in the pain management drugs & devices market are Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, Abbott.
The pain management drugs & devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pain Management Drugs & Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pain Management Drugs & Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pain Management Drugs & Devices Market - Supply Chain
4.5. Global Pain Management Drugs & Devices Market Forecast
4.5.1. Pain Management Drugs & Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pain Management Drugs & Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pain Management Drugs & Devices Market Absolute $ Opportunity
5. Global Pain Management Drugs & Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pain Management Drugs & Devices Market Size and Volume Forecast by Type
5.3.1. Pharmaceuticals
5.3.2. Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pain Management Drugs & Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pain Management Drugs & Devices Market Size and Volume Forecast by Application
6.3.1. Burn Pain
6.3.2. Cancer Pain
6.3.3. Dental/Facial Pain
6.3.4. Migraine Headache Pain
6.3.5. Musculoskeletal Pain
6.3.6. Neuropathic Pain
6.3.7. Obstetrical Pain
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pain Management Drugs & Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pain Management Drugs & Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pain Management Drugs & Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pain Management Drugs & Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pain Management Drugs & Devices Demand Share Forecast, 2019-2026
9. North America Pain Management Drugs & Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pain Management Drugs & Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pain Management Drugs & Devices Market Size and Volume Forecast by Application
9.4.1. Burn Pain
9.4.2. Cancer Pain
9.4.3. Dental/Facial Pain
9.4.4. Migraine Headache Pain
9.4.5. Musculoskeletal Pain
9.4.6. Neuropathic Pain
9.4.7. Obstetrical Pain
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pain Management Drugs & Devices Market Size and Volume Forecast by Type
9.7.1. Pharmaceuticals
9.7.2. Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pain Management Drugs & Devices Demand Share Forecast, 2019-2026
10. Latin America Pain Management Drugs & Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pain Management Drugs & Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pain Management Drugs & Devices Market Size and Volume Forecast by Application
10.4.1. Burn Pain
10.4.2. Cancer Pain
10.4.3. Dental/Facial Pain
10.4.4. Migraine Headache Pain
10.4.5. Musculoskeletal Pain
10.4.6. Neuropathic Pain
10.4.7. Obstetrical Pain
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pain Management Drugs & Devices Market Size and Volume Forecast by Type
10.7.1. Pharmaceuticals
10.7.2. Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pain Management Drugs & Devices Demand Share Forecast, 2019-2026
11. Europe Pain Management Drugs & Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pain Management Drugs & Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pain Management Drugs & Devices Market Size and Volume Forecast by Application
11.4.1. Burn Pain
11.4.2. Cancer Pain
11.4.3. Dental/Facial Pain
11.4.4. Migraine Headache Pain
11.4.5. Musculoskeletal Pain
11.4.6. Neuropathic Pain
11.4.7. Obstetrical Pain
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pain Management Drugs & Devices Market Size and Volume Forecast by Type
11.7.1. Pharmaceuticals
11.7.2. Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pain Management Drugs & Devices Demand Share, 2019-2026
12. Asia Pacific Pain Management Drugs & Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pain Management Drugs & Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pain Management Drugs & Devices Market Size and Volume Forecast by Application
12.4.1. Burn Pain
12.4.2. Cancer Pain
12.4.3. Dental/Facial Pain
12.4.4. Migraine Headache Pain
12.4.5. Musculoskeletal Pain
12.4.6. Neuropathic Pain
12.4.7. Obstetrical Pain
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pain Management Drugs & Devices Market Size and Volume Forecast by Type
12.7.1. Pharmaceuticals
12.7.2. Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pain Management Drugs & Devices Demand Share, 2019-2026
13. Middle East & Africa Pain Management Drugs & Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pain Management Drugs & Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pain Management Drugs & Devices Market Size and Volume Forecast by Application
13.4.1. Burn Pain
13.4.2. Cancer Pain
13.4.3. Dental/Facial Pain
13.4.4. Migraine Headache Pain
13.4.5. Musculoskeletal Pain
13.4.6. Neuropathic Pain
13.4.7. Obstetrical Pain
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pain Management Drugs & Devices Market Size and Volume Forecast by Type
13.7.1. Pharmaceuticals
13.7.2. Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pain Management Drugs & Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pain Management Drugs & Devices Market: Market Share Analysis
14.2. Pain Management Drugs & Devices Distributors and Customers
14.3. Pain Management Drugs & Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbvie Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Astrazeneca Depomed Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Djo Global Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eli Lilly & Co.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Endo International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Glaxosmithkline
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hisamitsu Pharmaceutical Co. Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Johnson & Johnson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medtronic Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novartis International Ag
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Pfizer
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Purdue Pharmaceuticals Lp
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Abbott
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook